Literature DB >> 6176666

Epitope-specific regulation. II. A bistable, Igh-restricted regulatory mechanism central to immunologic memory.

L A Herzenberg, T Tokuhisa, D R Parks, L A Herzenberg.   

Abstract

Antibody responses to commonly used antigens are regulated by an epitope- specific system composed of Igh-restricted elements responsible for controlling the isotype and allotype responses mounted to each of the epitopes on the antigen. Because these elements can be independently induced to either suppress or support antibody production, this system as a whole provides an effector mechanism capable of selectively controlling the amount, affinity, isotype representation, and epitope-specificity of an antibody response. Sequential immunizations with a carrier molecule and a hapten conjugated to that carrier (carrier/hapten-carrier immunization) induce suppression for IgG responses to the hapten. IgG(2a), IgG(2b), and IgG(3) responses are easily suppressed, whereas IgG(1) responses tend to be more resistant. Once induced, suppression tends to be maintained; however, repeated stimulation with the hapten (on any carrier) eventually induces antibody production, first for IgG(1) and later for the more suppressible isotypes (IgG(2a), IgG(2b), IgG(3)). Antibody production, once initiated, also tends to be maintained. Ongoing IgG antihapten responses in animals primed with a hapten-carrier conjugate can be suppressed by subsequent carrier/hapten-carrier immunization (using a different carrier molecule); however, the suppression induced under these circumstances is substantially weaker, i.e., it mainly affects the more suppressible isotypes and is only strong enough to detect clearly in about one-half the immunized animals. Thus, the initiation of antibody production impairs the subsequent induction of suppression, and the initial induction of suppression tends to prevent subsequent initiation of antibody production. This reciprocal relationship defines a bistable regulatory mechanism, i.e., one that tends to maintain its initially induced state but is capable of shifting to the alternate state when stimulatory conditions so dictate. The operation of such a mechanism permits conditions surrounding the first immunization with an epitope (hapten) to strongly influence but not absolutely determine which and how many of the anti-epitope memory B cells generated by that immunization will subsequently be expressed. Thus, epitope- specific regulation, although subordinate to mechanisms that control memory B cell development (as opposed to expression), plays a key role in determining the magnitude, affinity, and isotype representation of anamnestic (memory) responses produced in response to previously encountered epitopes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6176666      PMCID: PMC2186708          DOI: 10.1084/jem.155.6.1741

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  The carrier effect in the secondary response to hapten-protein conjugates. I. Measurement of the effect with transferred cells and objections to the local environment hypothesis.

Authors:  N A Mitchison
Journal:  Eur J Immunol       Date:  1971-01       Impact factor: 5.532

2.  Idiotype-specific T helper cells are required to induce idiotype-positive B memory cells to secrete antibody.

Authors:  R Woodland; H Cantor
Journal:  Eur J Immunol       Date:  1978-08       Impact factor: 5.532

3.  Recognition of idiotypes in lymphocyte interactions. II. Antigen-independent cooperation between T and B lymphocytes that possess similar and complementary idiotypes.

Authors:  K Eichmann; I Falk; K Rajewsky
Journal:  Eur J Immunol       Date:  1978-12       Impact factor: 5.532

4.  Regulatory circuits and antibody responses.

Authors:  L A Herzenberg; S J Black; L A Herzenberg
Journal:  Eur J Immunol       Date:  1980-01       Impact factor: 5.532

5.  Recognition of idiotypes in lymphocyte interactions. I. Idiotypic selectivity in the cooperation between T and B lymphocytes.

Authors:  D Hetzelberger; K Eichmann
Journal:  Eur J Immunol       Date:  1978-12       Impact factor: 5.532

Review 6.  T cell-dependent suppression of an anti-hapten antibody response.

Authors:  A Basten; J F Miller; P Johnson
Journal:  Transplant Rev       Date:  1975

7.  T-cell regulation of antibody responses: demonstration of allotype-specific helper T cells and their specific removal by suppressor T cells.

Authors:  L A Herzenberg; K Okumura; H Cantor; V L Sato; F W Shen; E A Boyse; L A Herzenberg
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

8.  The requirement of more than one antigenic determinant for immunogenicity.

Authors:  K Rajewsky; V Schirrmacher; S Nase; N K Jerne
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

9.  Induction of T-lymphocyte responses to a small molecular weight antigen. III. T-T cell interactions to determinants linked together: suppression vs. enhancement.

Authors:  W W Bullock; D H Katz; B Benacerraf
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

10.  Carrier function in anti-hapten immune responses. I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization.

Authors:  D H Katz; W E Paul; E A Goidl; B Benacerraf
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307

View more
  9 in total

1.  Stochastic humoral expression of human growth hormone epitopes.

Authors:  M Etcheverrigaray; A C Paladini; L A Retegui
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

2.  Assessment in mice of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, P. falciparum.

Authors:  H M Etlinger; E P Heimer; A Trzeciak; A M Felix; D Gillessen
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

3.  Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation.

Authors:  Mari Ohmura; Masafumi Yamamoto; Chikako Tomiyama-Miyaji; Yoshikazu Yuki; Yoshifumi Takeda; Hiroshi Kiyono
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

4.  Bypass of carrier-induced epitope-specific suppression using a T-helper epitope.

Authors:  S Sad; K Rao; R Arora; G P Talwar; R Raghupathy
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

5.  New approaches for control of infections using synthetic or semi-synthetic constructs containing MDP.

Authors:  L Chedid; F Audibert
Journal:  Springer Semin Immunopathol       Date:  1985

6.  Carrier-induced suppression of the antibody response to a 'self' hapten.

Authors:  S Sad; H M Gupta; G P Talwar; R Raghupathy
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

7.  The nature and combination of subunits used in epitope-based Schistosoma japonicum vaccine formulations affect their efficacy.

Authors:  Xuefeng Wang; Lei Zhang; Ying Chi; Jason Hoellwarth; Sha Zhou; Xiaoyun Wen; Lei He; Feng Liu; Calvin Wu; Chuan Su
Journal:  Parasit Vectors       Date:  2010-11-19       Impact factor: 3.876

8.  A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens.

Authors:  D A Rowley; R M Stach
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

Review 9.  Factors contributing to the immunogenicity of meningococcal conjugate vaccines.

Authors:  Michael Bröker; Francesco Berti; Paolo Costantino
Journal:  Hum Vaccin Immunother       Date:  2016-03-02       Impact factor: 3.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.